ciprofloxacin has been researched along with Atherosclerosis in 3 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Atherosclerosis: A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Initially, DDS for the treatment of atherosclerosis are described." | 2.44 | [Development of drug delivery systems for targeting to macrophages]. ( Chono, S, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Binesh, A | 1 |
| Devaraj Sivasitambaram, N | 1 |
| Halagowder, D | 1 |
| Wang, X | 1 |
| Zheng, Y | 1 |
| Ma, Y | 1 |
| Du, L | 1 |
| Chu, F | 1 |
| Gu, H | 1 |
| Dahlgren, RA | 1 |
| Li, Y | 1 |
| Wang, H | 1 |
| Chono, S | 1 |
1 review available for ciprofloxacin and Atherosclerosis
| Article | Year |
|---|---|
[Development of drug delivery systems for targeting to macrophages].
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Atherosclerosis; Ciprofloxacin; Dexamethas | 2007 |
2 other studies available for ciprofloxacin and Atherosclerosis
| Article | Year |
|---|---|
Monocytes treated with ciprofloxacin and oxyLDL express myristate, priming atherosclerosis.
Topics: Atherosclerosis; Ciprofloxacin; Gene Expression Regulation; Humans; Lipoproteins, LDL; Monocytes; My | 2020 |
Lipid metabolism disorder induced by up-regulation of miR-125b and miR-144 following β-diketone antibiotic exposure to F0-zebrafish (Danio rerio).
Topics: Animals; Anti-Bacterial Agents; Atherosclerosis; Chlortetracycline; Cholesterol; Ciprofloxacin; Comp | 2018 |